SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-24-142838
Filing Date
2024-05-20
Accepted
2024-05-20 16:05:59
Documents
2
Group Members
J. LUTHER KING, JR

Document Format Files

Seq Description Document Type Size
1 SC 13G d834770dsc13g.htm SC 13G 51197
2 EX-99.1 d834770dex991.htm EX-99.1 3270
  Complete submission text file 0001193125-24-142838.txt   56122
Mailing Address 301 COMMERCE SUITE 1600 FORT WORTH TX 76102
Business Address 301 COMMERCE SUITE 1600 FORT WORTH TX 76102 8173323235
KING LUTHER CAPITAL MANAGEMENT CORP (Filed by) CIK: 0000310051 (see all company filings)

IRS No.: 75163030 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 0000

Mailing Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803
Business Address 25 BURLINGTON MALL ROAD, SUITE 203 BURLINGTON MA 01803 617-517-0730
scPharmaceuticals Inc. (Subject) CIK: 0001604950 (see all company filings)

IRS No.: 465184075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90193 | Film No.: 24964414
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)